Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Astrid Blom

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Oncotarget|December 15, 2015
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapyGerald Goh, Trent Walradt, Vladimir Markarov, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvantDanielle Lienard, Marie-Françoise Avril, Frédérique-Anne Le Gal, et al.
Advances in Radiation Oncology|July 26, 2017
Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neckSeesha R Takagishi, Tessa E Marx, Christopher Lewis, et al.
The Journal of Investigative Dermatology|November 6, 2016
Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus DetectionAta S Moshiri, Ryan Doumani, Lola Yelistratova, et al.
American Journal of Clinical Pathology|August 20, 2017
CD200 Expression in Neuroendocrine NeoplasmsJason E Love, Kimberly Thompson, Mark R Kilgore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Cancer Medicine|April 25, 2015
Single-fraction radiation therapy in patients with metastatic Merkel cell carcinomaJayasri G Iyer, Upendra Parvathaneni, Ted Gooley, et al.
American Journal of Clinical Pathology|January 14, 2011
Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 casesClaire Bénet, Aurélie Gomez, Claire Aguilar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2019
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell CarcinomaShailender Bhatia, Natalie V Longino, Natalie J Miller, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Oncotarget|December 15, 2015
Mutational landscape of MCPyV-positive and MCPyV-negative Merkel cell carcinomas with implications for immunotherapyGerald Goh, Trent Walradt, Vladimir Markarov, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Vaccination of melanoma patients with Melan-A/Mart-1 peptide and Klebsiella outer membrane protein p40 as an adjuvantDanielle Lienard, Marie-Françoise Avril, Frédérique-Anne Le Gal, et al.
Advances in Radiation Oncology|July 26, 2017
Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neckSeesha R Takagishi, Tessa E Marx, Christopher Lewis, et al.
The Journal of Investigative Dermatology|November 6, 2016
Polyomavirus-Negative Merkel Cell Carcinoma: A More Aggressive Subtype Based on Analysis of 282 Cases Using Multimodal Tumor Virus DetectionAta S Moshiri, Ryan Doumani, Lola Yelistratova, et al.
American Journal of Clinical Pathology|August 20, 2017
CD200 Expression in Neuroendocrine NeoplasmsJason E Love, Kimberly Thompson, Mark R Kilgore, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2018
Circulating Cell-Free miR-375 as Surrogate Marker of Tumor Burden in Merkel Cell CarcinomaKaiji Fan, Cathrin Ritter, Paul Nghiem, et al.
Cancer Medicine|April 25, 2015
Single-fraction radiation therapy in patients with metastatic Merkel cell carcinomaJayasri G Iyer, Upendra Parvathaneni, Ted Gooley, et al.
American Journal of Clinical Pathology|January 14, 2011
Histologic and immunohistologic characterization of skin localization of myeloid disorders: a study of 173 casesClaire Bénet, Aurélie Gomez, Claire Aguilar, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Avelumab as second-line or later treatment in patients with metastatic Merkel cell carcinoma: Analysis of real-world outcomes in France using the CARADERM database linked to the French national healthcare databaseLaurent Mortier, Astrid Blom, Benoît van Hille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2019
Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell CarcinomaShailender Bhatia, Natalie V Longino, Natalie J Miller, et al.
Pageof 4